New clinical data shows enoxaparin reduces risk of repeat heart attacks and stroke in patients undergoing PCI.
D000925:Anticoagulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017984:Enoxaparin / Q000627:therapeutic use*; D006801:Humans; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D017984:Enoxaparin